International Journal of Endocrinology

Type 2 Diabetes and Cardiovascular Risk in Women 2016


Status
Published

1Medical University of Vienna, Vienna, Austria

2Università di Padova, Padua, Italy

3CORESEARCH - Center for Outcomes Research and ClinicalEpidemiology, Pescara, Italy

4Padova University, Padua, Italy

5University of Messina, Messina, Italy


Type 2 Diabetes and Cardiovascular Risk in Women 2016

Description

Cardiovascular diseases (CVDs) are the leading cause of death, especially in women. Women generally have a ~10-year delay in the onset of cardiovascular events as compared to men; however, diabetes seems to eliminate this “gender advantage,” with diabetic women showing even a higher risk for coronary heart disease (CHD) than diabetic men. Furthermore, diabetic women are more unlikely to achieve a good metabolic control than men and, overall, show a worse CVD risk profile. These sex discrepancies in terms of diabetes-related CVD complications have attracted the interest of clinicians and researchers, since they are not entirely attributable to a diverse prevalence of CVD risk factors or to different therapeutic strategies.

Thus, beyond chronic hyperglycaemia, a number of other factors such as dyslipidemia, hypertension, hormonal, genetic, and environmental factors and low-grade systemic inflammation and endothelial damage may contribute to a different impact to the atherosclerosis process associated with diabetes in women. Many of these factors show gender differences in their prevalence and /or association with CVD events.

We invite investigators to submit original research as well as review articles aimed to explore the peculiarity of CVD in women with type 2 diabetes.

Potential topics include, but are not limited to:

  • CVD risk definition in the clinical practice
  • Role of atherogenic dyslipidemia, exploring “quantitative” and “qualitative” alterations of lipid pattern in diabetic women
  • Contribution of menopause in CVD risk definition
  • Diabetic nephropathy and CVD in diabetic women
  • Differences in treatments and personalized therapeutic strategies
  • Chronic inflammation and endothelial dysfunction
  • Impact of “minor” CHD risk factors and residual risk
  • Obesity and central adiposity in women
  • Microcirculation and diabetes in women
  • Impact of genetic background on metabolic profile and CVD risk in women
  • Diet in diabetic women
  • Psychosocial issues and adherence to treatment

Articles

  • Special Issue
  • - Volume 2017
  • - Article ID 6905697
  • - Editorial

Type 2 Diabetes and Cardiovascular Risk in Women 2016

Alexandra Kautzky-Willer | Giovannella Baggio | ... | Giuseppina T. Russo
  • Special Issue
  • - Volume 2017
  • - Article ID 6039356
  • - Research Article

Sex Differences in the Effect of Type 2 Diabetes on Major Cardiovascular Diseases: Results from a Population-Based Study in Italy

Paola Ballotari | Francesco Venturelli | ... | Valeria Manicardi
  • Special Issue
  • - Volume 2016
  • - Article ID 1615735
  • - Review Article

Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences

Giuseppina T. Russo | Annalisa Giandalia | ... | Domenico Cucinotta
  • Special Issue
  • - Volume 2016
  • - Article ID 2070926
  • - Review Article

Gestational Diabetes Mellitus and Future Cardiovascular Risk: An Update

S. Burlina | M. G. Dalfrà | ... | A. Lapolla
  • Special Issue
  • - Volume 2016
  • - Article ID 2647865
  • - Research Article

Cardiometabolic Risk in Hyperlipidemic Men and Women

Michael Leutner | Christian Göbl | ... | Alexandra Kautzky-Willer
  • Special Issue
  • - Volume 2016
  • - Article ID 6380620
  • - Research Article

Stroke Risk among Patients with Type 2 Diabetes Mellitus in Zhejiang: A Population-Based Prospective Study in China

Lihua Guo | Min Yu | ... | Ruying Hu
International Journal of Endocrinology
 Journal metrics
Acceptance rate35%
Submission to final decision48 days
Acceptance to publication46 days
CiteScore3.500
Impact Factor2.299
 Submit